Evidence map›Paper›PMID 36684092›Full record

ReviewBioengineering & translational medicine2023

Biomedical applications of three-dimensional bioprinted craniofacial tissue engineering.

Nitin Bharat Charbe, Murtaza Tambuwala, Sushesh Srivatsa Palakurthi, Amol Warokar, Altijana Hromić-Jahjefendić, Hamid Bakshi, Flavia Zacconi, Vijay Mishra, Saurabh Khadse, Alaa A Aljabali and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Bioengineering & translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 7 countries.

Nitin Bharat CharbeIrma Lerma Rangel College of Pharmacy Texas A&M Health Science Center Kingsville Texas USA.
Murtaza TambuwalaSchool of Pharmacy and Pharmaceutical Science Ulster University Coleraine UK.ORCID https://orcid.org/0000-0001-8499-9891
Sushesh Srivatsa PalakurthiIrma Lerma Rangel College of Pharmacy Texas A&M Health Science Center Kingsville Texas USA.
Amol WarokarDepartment of Pharmacy Dadasaheb Balpande College of Pharmacy Nagpur India.
Altijana Hromić-JahjefendićDepartment of Genetics and Bioengineering, Faculty of Engineering and Natural Sciences International University of Sarajevo Sarajevo Bosnia and Herzegovina.
Hamid BakshiSchool of Pharmacy and Pharmaceutical Science Ulster University Coleraine UK.
Flavia ZacconiDepartamento de Quimica Orgánica, Facultad de Química y de Farmacia Pontificia Universidad Católica de Chile Santiago Chile.
Vijay MishraSchool of Pharmaceutical Sciences Lovely Professional University Phagwara India.ORCID https://orcid.org/0000-0001-6542-2464
Saurabh KhadseDepartment of Pharmaceutical Chemistry R.C. Patel Institute of Pharmaceutical Education and Research Dhule India.
Alaa A AljabaliFaculty of Pharmacy, Department of Pharmaceutical Sciences Yarmouk University Irbid Jordan.
Mohamed El-TananiPharmacological and Diagnostic Research Centre, Faculty of Pharmacy Al-Ahliyya Amman University Amman Jordan.
Ãngel Serrano-ArocaBiomaterials and Bioengineering Lab Translational Research Centre San Alberto Magno Catholic University of Valencia San Vicente Mártir Valencia Spain.ORCID https://orcid.org/0000-0002-9953-3848
Srinath PalakurthiIrma Lerma Rangel College of Pharmacy Texas A&M Health Science Center Kingsville Texas USA.
Texas A&M Health Science Center · USUniversity of Ulster · GBAl-Ahliyya Amman University · JOHindu College of Pharmacy · INInternational University of Sarajevo · BALovely Professional University · INPontificia Universidad Católica de Chile · CLShri Vile Parle Kelavani Mandal · INUniversitat de València · ESYarmouk University · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anatomical complications of the craniofacial regions often present considerable challenges to the surgical repair or replacement of the damaged tissues. Surgical repair has its own set of limitations, including scarcity of the donor tissues, immune rejection, use of immune suppressors followed by the surgery, and restriction in restoring the natural aesthetic appeal. Rapid advancement in the field of biomaterials, cell biology, and engineering has helped scientists to create cellularized skeletal muscle-like structures. However, the existing method still has limitations in building large, highly vascular tissue with clinical application. With the advance in the three-dimensional (3D) bioprinting technique, scientists and clinicians now can produce the functional implants of skeletal muscles and bones that are more patient-specific with the perfect match to the architecture of their craniofacial defects. Craniofacial tissue regeneration using 3D bioprinting can manage and eliminate the restrictions of the surgical transplant from the donor site. The concept of creating the new functional tissue, exactly mimicking the anatomical and physiological function of the damaged tissue, looks highly attractive. This is crucial to reduce the donor site morbidity and retain the esthetics. 3D bioprinting can integrate all three essential components of tissue engineering, that is, rehabilitation, reconstruction, and regeneration of the lost craniofacial tissues. Such integration essentially helps to develop the patient-specific treatment plans and damage site-driven creation of the functional implants for the craniofacial defects. This article is the bird's eye view on the latest development and application of 3D bioprinting in the regeneration of the skeletal muscle tissues and their application in restoring the functional abilities of the damaged craniofacial tissue. We also discussed current challenges in craniofacial bone vascularization and gave our view on the future direction, including establishing the interactions between tissue-engineered skeletal muscle and the peripheral nervous system.

Indexed as

3D bioprintingbioengineeringbiomaterialscraniofacial tissue complexsoft tissues

Identifiers

PMID36684092
PMCPMC9842068
OpenAlexW4280488281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.